• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍儿童和青少年临床指南综述及其在爱尔兰背景下的应用。

Review of clinical guidelines for children and adolescents with attention deficit hyperactivity disorder and their application to an Irish context.

作者信息

Kavanagh G, O'Hanrahan S, Hughes G, McNicholas F

机构信息

1Consultant Child and Adolescent Psychiatrist,Lucena Clinic,Wicklow,Ireland.

2Research Psychologist,Department of Child and Adolescent Psychiatry,Our Lady's Children's Hospital,Crumlin,Dublin,Ireland.

出版信息

Ir J Psychol Med. 2015 Sep;32(3):283-293. doi: 10.1017/ipm.2014.63.

DOI:10.1017/ipm.2014.63
PMID:30185262
Abstract

BACKGROUND

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with international prevalence rates estimated to be 5%. It is currently the most common disorder treated in Child and Adolescent Mental Health Services in Ireland. There have been a number of guidelines worldwide produced to aid clinicians in the diagnosis and treatment of ADHD; however, there are no guidelines available specifically for the Irish population and healthcare system.

OBJECTIVES

The aim of this paper is to review the available clinical guidelines for the diagnosis and management of ADHD in children adolescents across North America, Canada, Europe and the United Kingdom and to apply these to an Irish context.

METHODS

A number of international guidelines were reviewed. A proposed pathway for the assessment and treatment of children and adolescents with ADHD has been devised with the recommendation that a formalised consensus guideline should be implemented.

CONCLUSION

This review paper has highlighted that there is consensus between the guidelines for the diagnosis of ADHD with a thorough clinical history remaining the gold standard. They further agree on the importance of identifying co-morbid disorders. When it comes to the treatment, the guidelines are less unified. This current paper has devised a proposed care pathway for ADHD in Ireland to ensure high quality cost effective care within its healthcare system.

摘要

背景

注意力缺陷多动障碍(ADHD)是一种神经发育障碍,据估计其在全球的患病率为5%。它是爱尔兰儿童和青少年心理健康服务中目前最常治疗的疾病。全球已经出台了一些指南来帮助临床医生诊断和治疗ADHD;然而,目前没有专门针对爱尔兰人群和医疗保健系统的指南。

目的

本文的目的是回顾北美、加拿大、欧洲和英国关于儿童青少年ADHD诊断和管理的现有临床指南,并将其应用于爱尔兰的情况。

方法

对一些国际指南进行了回顾。设计了一个针对ADHD儿童和青少年的评估和治疗建议路径,并建议实施正式的共识指南。

结论

这篇综述文章强调,ADHD诊断指南之间存在共识,详尽的临床病史仍是金标准。它们还就识别共病的重要性达成了一致。在治疗方面,指南的一致性较低。本文为爱尔兰设计了一个ADHD的建议护理路径,以确保其医疗保健系统内高质量、具有成本效益的护理。

相似文献

1
Review of clinical guidelines for children and adolescents with attention deficit hyperactivity disorder and their application to an Irish context.注意缺陷多动障碍儿童和青少年临床指南综述及其在爱尔兰背景下的应用。
Ir J Psychol Med. 2015 Sep;32(3):283-293. doi: 10.1017/ipm.2014.63.
2
Review of international clinical guidelines for adolescents on transition to Adult Mental Health Services and adults with attention-deficit hyperactivity disorder and their application to an irish context.青少年向成人心理健康服务过渡及成人注意力缺陷多动障碍的国际临床指南综述及其在爱尔兰背景下的应用
Ir J Psychol Med. 2017 Mar;34(1):59-73. doi: 10.1017/ipm.2015.62.
3
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
4
The clinical pathway in ADMiRE, Ireland's first public specialist service for children and adolescents with attention deficit hyperactivity disorder.ADMiRE的临床路径,这是爱尔兰首个针对患有注意力缺陷多动障碍的儿童和青少年的公共专科服务。
Ir J Psychol Med. 2024 Jun 3:1-8. doi: 10.1017/ipm.2024.13.
5
Co-morbidity in Attention-Deficit Hyperactivity Disorder: A Clinical Study from India.注意缺陷多动障碍的共病情况:一项来自印度的临床研究。
East Asian Arch Psychiatry. 2016 Dec;26(4):148-53.
6
[Attention-deficit/hyperactivity disorder in childhood/adolescence and impairments associated with daily life: French data from the European Lifetime Impairment Survey].[儿童/青少年注意力缺陷/多动障碍及与日常生活相关的损害:来自欧洲终身损害调查的法国数据]
Arch Pediatr. 2014 Dec;21(12):1283-92. doi: 10.1016/j.arcped.2014.08.035. Epub 2014 Oct 7.
7
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的儿童和青少年的健康相关生活质量。
Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844.
8
Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.加拿大关于注意缺陷多动障碍、对立违抗障碍或品行障碍的儿童及青少年破坏性行为和攻击性行为药物治疗的指南。
Can J Psychiatry. 2015 Feb;60(2):62-76. doi: 10.1177/070674371506000204.
9
Diagnosing attention-deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?诊断涉及儿童保护服务的儿童的注意力缺陷多动障碍(ADHD):当前的诊断指南对弱势群体是否适用?
Child Care Health Dev. 2015 Mar;41(2):178-85. doi: 10.1111/cch.12168. Epub 2014 Jun 18.
10
Clinical Practice Guidelines for the Evaluation and Diagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A systematic review of the literature.儿童和青少年注意缺陷多动障碍评估和诊断的临床实践指南:文献系统回顾。
Sultan Qaboos Univ Med J. 2021 Feb;21(1):e12-e21. doi: 10.18295/squmj.2021.21.01.003. Epub 2021 Mar 15.

引用本文的文献

1
Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015.爱尔兰儿童和青年人群中注意缺陷多动障碍(ADHD)药物使用趋势:2005 年至 2015 年的重复横断面研究。
BMJ Open. 2020 Apr 22;10(4):e035716. doi: 10.1136/bmjopen-2019-035716.
2
What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review.全科医生对注意力缺陷多动障碍了解多少?首诊把关者的态度和知识:系统叙述性综述。
BMC Fam Pract. 2016 Sep 7;17(1):129. doi: 10.1186/s12875-016-0516-x.